Condition: Acute Disease · Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
This description comes directly from the study's public registry record.
Diana Gutiérrez, MD · +34938960025 · dpgutierrez@csapg.cat
Noemí Casaponsa · +34 938960025 · recerca@csapg.cat
Always discuss trial participation with your own doctor first.
| CSAPG | Sant Pere de Ribes, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07007156